December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
Psoriatic Uveitis: An Established Clinical Entity
Author Affiliations & Notes
  • C Foster
    Ophthalmology Mass Eye & Ear Infirmary Boston MA
  • K Durrani
    Ophthalmology Mass Eye & Ear Infirmary Boston MA
  • Footnotes
    Commercial Relationships   C. Foster, None; K. Durrani, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 4254. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C Foster, K Durrani; Psoriatic Uveitis: An Established Clinical Entity . Invest. Ophthalmol. Vis. Sci. 2002;43(13):4254.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: The aim of this study is to provide a clinical description of uveitis occurring in psoriatic patients, and to allow further epidemiologic testing of the strength of association between the two conditions. Method: The records of forty two consecutive patients with a dual diagnosis of psoriasis and uveitis attending the Uveitis Service at the Massachusetts Eye & Ear Infirmary were reviewed. Clinical characteristics were determined and chi square and Fisher exact tests were used to determine associations between HLA-B27 positivity and severity of inflammation and treatment required. Results: Initial review revealed 42 patients with a diagnosis psoriasis and uveitis. Sarcoidosis was diagnosed in two, and CNS-intraocular lymphoma in one of these patients. Of the remaining 39 patients, uveitis tended to be anterior (71.8% of patients), recurrent (84.7%), and in many cases, bilateral (48.7%), with a mean maximum grade of cells being 1.4 (SD 1.3). Associated retinal findings included cystoid macula edema (20.5%), retinal vasculitis (10.3%), and discrete atrophic retinal lesions (7.7%). HLA-B27 positivity was not associated with severity of inflammation (p=0.37). However, HLA-B27 positive patients were more likely to require oral non-steroidal anti-inflammatory drugs (RR 2.94, p=0.012) or systemic immunomodulation, using Methotrexate (RR 3.47, p=0.022) for control and prophylaxis of ocular inflammation. Conclusion: Psoriatic uveitis may be a separate clinical entity and can have associated retinal findings. Patients with psoriasis who are HLA-B27 positive are more likely to require oral NSAID or systemic immunomodulation than HLA-B27 negative patients. Further epidemiologic tests are required to determine the strength of association between psoriasis and uveitis.

Keywords: 612 uveitis-clinical/animal model • 353 clinical (human) or epidemiologic studies: outcomes/complications 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.